Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/14/2025

Management of Severe Hypokalemia

Target Serum Potassium Levels

  • The American College of Cardiology recommends a target serum potassium level of 4.0-4.5 mEq/L 1

Treatment Considerations

  • For patients with autoimmune diseases, such as the one described, who are on medications that cause potassium wasting (e.g., corticosteroids), the European Society of Cardiology suggests considering adding potassium-sparing diuretics if hypokalemia persists despite supplementation 2
  • The American College of Cardiology recommends that for persistent hypokalemia, potassium-sparing agents such as spironolactone, triamterene, or amiloride may be considered 1

Potential Complications and Cautions

  • The American College of Cardiology advises caution when administering potassium supplements with concomitant ACE inhibitors or potassium-sparing diuretics as dangerous hyperkalemia may occur 1
  • The American College of Cardiology recommends avoiding nonsteroidal anti-inflammatory drugs in patients with hypokalemia as they can worsen electrolyte imbalances 1